EVAX – evaxion biotech a/s - american depositary share (US:NASDAQ)
Stock Stats
News
Evaxion expands AI-Immunology™ platform into autoimmune diseases
Evaxion A/S (NASDAQ:EVAX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2 [Yahoo! Finance]
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2
Form 6-K Evaxion A/S For: Jan 13
Form 6-K Evaxion A/S For: Jan 07
Form 6-K Evaxion A/S For: Dec 19
Form 6-K Evaxion A/S For: Dec 10
Form 424B5 Evaxion A/S
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.